מיפג'ין

Country: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
15-08-2022

Bahan aktif:

MIFEPRISTONE

Boleh didapati daripada:

A. LAPIDOT PHARMACEUTICALS, LTD

Kod ATC:

G03XB01

Borang farmaseutikal:

טבליה

Komposisi:

MIFEPRISTONE 200 MG

Laluan pentadbiran:

פומי

Jenis preskripsi:

מרשם נדרש

Dikeluarkan oleh:

EXELGYNE LABORATORIES, FRANCE

Kumpulan terapeutik:

MIFEPRISTONE

Kawasan terapeutik:

MIFEPRISTONE

Tanda-tanda terapeutik:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Tarikh kebenaran:

2014-07-31

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Inggeris 25-07-2022
Ciri produk Ciri produk Inggeris 25-07-2022
Laporan Penilaian Awam Laporan Penilaian Awam Inggeris 11-10-2022
Risalah maklumat Risalah maklumat Arab 25-07-2022

Cari amaran yang berkaitan dengan produk ini

Lihat sejarah dokumen